New technology can potentially overcome CAR T-cell limitations
27 Apr 2016
New technology can potentially overcome CAR T-cell limitations
AML17 Trial results: maximum dosage of daunorubicin in AML
AML during pregancy
Germ line predisposition to leukaemia
The future of haematopathology
Frontline therapy in young patients with myeloma
Genomics of childhood ALL
Cell of origin role in cancer stem cell and GBM phenotype
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations
MINDACT breast cancer clinical trial: First results and impact on future trial design
Breast cancer research news from AACR President Nancy Davidson
Non-coding mutations driving chronic lymphocytic leukaemia